Antibody

Amyloid β [1-42] and Aβ [1-40]

Tools

Back to the Top

Clonality: kit
Host: Unknown Host
Methods: ELISA
Source: Innogenetics
cat# 80933
INNO-BIA
blood ß-amyloid kit
Leaflet
References:
Siderowf, 2010
Fagan, 2009
Lambert, 2009
Formulation: well standardized multiparameter bead-based immunoassay for the simultaneous quantification of human ß-amyloid in plasma using xMAP® (registered trademark of Luminex Corp)technology
Reactivity:
Reacts in: Human

Immunogen/Epitope

Uses 3D6 antibody;
3D6 selectively binds Aß peptides with a free amino
group at Asp1 (epitope 1–5)

Specificity

for simultaneous quantification of different forms of β-amyloid in blood, with check for matrix interference

Note

see details

Comments / Questions

Make a comment or submit a question

To make a comment you must login or register.

Comments on this content

No Available Comments

References

Paper Citations

  1. . CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease. Neurology. 2010 Sep 21;75(12):1055-61. PubMed.
  2. . Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease. EMBO Molecular Medicine. 2009 Nov 1;1(8-9):371-380.
  3. . Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology. 2009 Sep 15;73(11):847-53. PubMed.

External Citations

  1. Leaflet
  2. details

Further Reading

No Available Further Reading